Production of human antibody repertoires in transgenic mice
- PMID: 9265725
- DOI: 10.1016/s0958-1669(97)80068-7
Production of human antibody repertoires in transgenic mice
Abstract
Transgenic mice have been created that carry human immunoglobulin heavy and light chain genes in germline configuration and that have the corresponding endogenous genes silenced. The transgenes are either minigene constructs or large, almost authentic, transloci on yeast artificial chromosomes and undergo B-cell-specific DNA rearrangement and hypermutation in the mouse lymphoid tissue. Monoclonal antibodies with good affinities for human antigens have been obtained after immunisation. These mice may be a future source of human antibodies for therapy.
Similar articles
-
Production of antigen-specific human antibodies from mice engineered with human heavy and light chain YACs.Ann N Y Acad Sci. 1995 Sep 29;764:525-35. doi: 10.1111/j.1749-6632.1995.tb55878.x. Ann N Y Acad Sci. 1995. PMID: 7486581
-
Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice.Nat Genet. 1997 Feb;15(2):146-56. doi: 10.1038/ng0297-146. Nat Genet. 1997. PMID: 9020839
-
Antigen-Specific Human Monoclonal Antibodies from Transgenic Mice.Methods Mol Biol. 2019;1904:253-291. doi: 10.1007/978-1-4939-8958-4_11. Methods Mol Biol. 2019. PMID: 30539474
-
Human antibody expression in transgenic mice.Arch Immunol Ther Exp (Warsz). 2001;49(3):203-8. Arch Immunol Ther Exp (Warsz). 2001. PMID: 11478394 Review.
-
Strategies for expressing human antibody repertoires in transgenic mice.Immunol Today. 1996 Aug;17(8):391-7. doi: 10.1016/0167-5699(96)10025-6. Immunol Today. 1996. PMID: 8783501 Review.
Cited by
-
New biologic agents: a critical appraisal.Curr Gastroenterol Rep. 1999 Dec;1(6):470-5. doi: 10.1007/s11894-999-0005-7. Curr Gastroenterol Rep. 1999. PMID: 10980988 Review.
-
Regulation of B cell development by variable gene complexity in mice reconstituted with human immunoglobulin yeast artificial chromosomes.J Exp Med. 1998 Aug 3;188(3):483-95. doi: 10.1084/jem.188.3.483. J Exp Med. 1998. PMID: 9687526 Free PMC article.
-
Inhibition of complement as a therapeutic approach in inflammatory central nervous system (CNS) disease.Mol Med. 1999 Sep;5(9):569-82. Mol Med. 1999. PMID: 10551898 Free PMC article. Review. No abstract available.
-
Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.Clin Microbiol Rev. 2004 Oct;17(4):926-41, table of contents. doi: 10.1128/CMR.17.4.926-941.2004. Clin Microbiol Rev. 2004. PMID: 15489355 Free PMC article. Review.
-
Botulinum neurotoxins and botulism: a novel therapeutic approach.Toxins (Basel). 2011 May;3(5):469-88. doi: 10.3390/toxins3050469. Epub 2011 May 13. Toxins (Basel). 2011. PMID: 22069720 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources